{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:20:29Z","timestamp":1763018429558,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00404-021-06320-3","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T12:03:32Z","timestamp":1636632212000},"page":"1215-1223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The optimal time for the initiation of in vitro fertilization and embryo transfer among women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertility-sparing treatment"],"prefix":"10.1007","volume":"305","author":[{"given":"Ziyi","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zerui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianliu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5873-2146","authenticated-orcid":false,"given":"Qun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"issue":"2","key":"6320_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115\u2013132","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"6320_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"6320_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/01.AOG.0000255980.88205.15","volume":"109","author":"NK Lee","year":"2007","unstructured":"Lee NK, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS et al (2007) Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol 109(3):655\u2013662","journal-title":"Obstet Gynecol"},{"issue":"7","key":"6320_CR4","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1097\/IGC.0000000000000493","volume":"25","author":"A Rodolakis","year":"2015","unstructured":"Rodolakis A, Biliatis I, Morice P, Reed N, Mangler M, Kesic V et al (2015) European Society of Gynecological Oncology Task Force for fertility preservation: clinical recommendations for fertility sparing management in young endometrial cancer patients. Int J Gynecol Cancer 25(7):1258\u20131265","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"6320_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/annonc\/mdv484","volume":"27","author":"N Colombo","year":"2016","unstructured":"Colombo N, Creutzberg C, Amant F, Bosse T, Gonz\u00e1lez-Mart\u00edn A, Ledermann J et al (2016) ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol 27(1):16\u201341","journal-title":"Ann Oncol"},{"issue":"3","key":"6320_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ijgo.2015.06.031","volume":"131","author":"GM Gressel","year":"2015","unstructured":"Gressel GM, Parkash V, Pal L (2015) Management options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancer. Int J Gynaecol Obstet 131(3):234\u2013239","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"6320_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ygyno.2015.09.078","volume":"139","author":"R Zhou","year":"2015","unstructured":"Zhou R, Yang Y, Lu Q, Wang J, Miao Y, Wang S et al (2015) Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients. Gynecol Oncol 139(3):424\u2013428","journal-title":"Gynecol Oncol"},{"key":"6320_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12958-015-0136-7","volume":"14","author":"O Inoue","year":"2016","unstructured":"Inoue O, Hamatani T, Susumu N, Yamagami W, Ogawa S, Takemoto T et al (2016) Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia. Reprod Biol Endocrinol 14:2","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"6320_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tjog.2009.10.006","volume":"50","author":"AS Chao","year":"2011","unstructured":"Chao AS, Chao A, Wang CJ, Lai CH, Wang HS (2011) Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: case series and literature review. Taiwan J Obstet Gynecol 50(1):62\u201366","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"4","key":"6320_CR10","doi-asserted-by":"publisher","first-page":"266.e1","DOI":"10.1016\/j.ajog.2012.08.011","volume":"207","author":"ID Gallos","year":"2012","unstructured":"Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK (2012) Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and meta analysis. Am J Obstet Gynecol 207(4):266.e1\u201312","journal-title":"Am J Obstet Gynecol"},{"issue":"5 Pt 1","key":"6320_CR11","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0002-9378(99)70120-1","volume":"181","author":"R Rivera","year":"1999","unstructured":"Rivera R, Yacobson I, Grimes D (1999) The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol 181(5 Pt 1):1263\u20131269","journal-title":"Am J Obstet Gynecol"},{"key":"6320_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ygyno.2021.01.001","volume":"161","author":"OV Novikova","year":"2021","unstructured":"Novikova OV, Nosov VB, Panov VA, Novikova EG, Krasnopolskaya KV, Andreeva YY et al (2021) Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer. Gynecol Oncol 161:152","journal-title":"Gynecol Oncol"},{"issue":"11","key":"6320_CR13","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1038\/sj.bjc.6605086","volume":"100","author":"S Silva Idos","year":"2009","unstructured":"Silva Idos S, Wark PA, McCormack VA, Mayer D, Overton C, Little V et al (2009) Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer 100(11):1824\u20131831","journal-title":"Br J Cancer"},{"issue":"7","key":"6320_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/aje\/kwi084","volume":"161","author":"MD Althuis","year":"2005","unstructured":"Althuis MD, Moghissi KS, Westhoff CL, Scoccia B, Lamb EJ, Lubin JH et al (2005) Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 161(7):607\u2013615","journal-title":"Am J Epidemiol"},{"issue":"5","key":"6320_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0015-0282(01)01748-4","volume":"75","author":"MK Clark","year":"2001","unstructured":"Clark MK, Sowers M, Levy BT, Tenhundfeld P (2001) Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception. Fertil Steril 75(5):871\u2013877","journal-title":"Fertil Steril"},{"issue":"4","key":"6320_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1210\/jcem-30-4-449","volume":"30","author":"GG Gordon","year":"1970","unstructured":"Gordon GG, Southren AL, Tochimoto S, Olivo J, Altman K, Rand J et al (1970) Effect of medroxyprogesterone acetate (Provera) on the metabolism and biological activity of testosterone. J Clin Endocrinol Metab 30(4):449\u2013456. https:\/\/doi.org\/10.1210\/jcem-30-4-449","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6320_CR17","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/1097-0142(19840915)54:1+<1208::AID-CNCR2820541319>3.0.CO;2-K","volume":"54","author":"HC Blossey","year":"1984","unstructured":"Blossey HC, Wander HE, Koebberling J, Nagel GA (1984) Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer 54(6):1208\u20131215","journal-title":"Cancer"},{"issue":"2","key":"6320_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0015-0282(16)48016-7","volume":"42","author":"S Bassol","year":"1984","unstructured":"Bassol S, Garza-Flores J, Cravioto MC, Diaz-Sanchez V, Fotherby K, Lichtenberg R et al (1984) Ovarian function following a single administration of depomedroxy progesterone acetate (DMPA) at different doses, development, and research training in human reproduction, World Health Organization, Geneva Switzerland. Fertil Steril 42(2):216\u2013222","journal-title":"Fertil Steril"},{"issue":"5","key":"6320_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/00006250-198605000-00019","volume":"67","author":"J Wortsman","year":"1986","unstructured":"Wortsman J, Khan MS, Rosner W (1986) Suppression of testosterone-estradiol binding globulin by medroxyprogesterone acetate in polycystic ovary syndrome. Obstet Gynecol 67(5):705\u2013709","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"6320_CR20","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","volume":"46","author":"AE Schindler","year":"2003","unstructured":"Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH (2003) Classification and pharmacology of progestins. Maturitas 46(Suppl 1):S7\u2013S16","journal-title":"Maturitas"},{"issue":"1","key":"6320_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","volume":"27","author":"B Ata","year":"2021","unstructured":"Ata B, Capuzzo M, Turkgeldi E, Yildiz S, La Marca A (2021) Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses. Hum Reprod Update 27(1):48\u201366","journal-title":"Hum Reprod Update"},{"key":"6320_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/CLEP.S226414","volume":"12","author":"Q Xi","year":"2020","unstructured":"Xi Q, Tao Y, Qiu M, Wang Y, Kuang Y (2020) Comparison between PPOS and GnRHa-long protocol in clinical outcome with the first IVF\/ICSI cycle: a randomized clinical trial. Clin Epidemiol 12:261\u2013272","journal-title":"Clin Epidemiol"},{"issue":"8","key":"6320_CR23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1089\/ars.2019.7986","volume":"32","author":"AE Peters","year":"2020","unstructured":"Peters AE, Mihalas BP, Bromfield EG, Roman SD, Nixon B, Sutherland JM (2020) Autophagy in female fertility: a role in oxidative stress and aging. Antioxid Redox Signal 32(8):550\u2013568","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"6320_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","volume":"101","author":"M Koskas","year":"2014","unstructured":"Koskas M, Uzan J, Luton D, Rouzier R, Dara\u00ef E (2014) Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis. Fertil Steril 101(3):785\u2013794","journal-title":"Fertil Steril"},{"issue":"4","key":"6320_CR25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00404-019-05237-2","volume":"300","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Choe SA, Kim MK, Yun BS, Seong SJ, Kim YS (2019) Outcomes of in vitro fertilization cycles following fertility-sparing treatment in stage IA endometrial cancer. Arch Gynecol Obstet 300(4):975\u2013980","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"6320_CR26","first-page":"741","volume":"38","author":"XG Du","year":"2018","unstructured":"Du XG, Song XL, Li R, Li HZ, Qiao J (2018) Analysis of the clinical outcome of in vitro fertilization in infertility patients with conservative treatment of atypical endometrial hyperplasia and early well-differentiated endometrial adenocarcinoma. Reprod Contracept 38(9):741\u2013747","journal-title":"Reprod Contracept"},{"issue":"9","key":"6320_CR27","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s10815-014-0297-x","volume":"31","author":"A Fujimoto","year":"2014","unstructured":"Fujimoto A, Ichinose M, Harada M, Hirata T, Osuga Y, Fujii T (2014) The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer. J Assist Reprod Gene 31(9):1189\u20131194","journal-title":"J Assist Reprod Gene"},{"issue":"2","key":"6320_CR28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/IGC.0b013e31827c18a1","volume":"23","author":"M Ichinose","year":"2013","unstructured":"Ichinose M, Fujimoto A, Osuga Y, Minaguchi T, Kawana K, Yano T et al (2013) The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia. Int J Gynecol Cancer 23(2):288\u2013293","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"6320_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/ijgc-2018-000036","volume":"29","author":"SH Chae","year":"2019","unstructured":"Chae SH, Shim SH, Lee SJ, Lee JY, Kim SN, Kang SB (2019) Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer. Int J Gynecol Cancer 29(1):77\u201385","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"6320_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/AOG.0b013e31827a0643","volume":"121","author":"JY Park","year":"2013","unstructured":"Park JY, Seong SJ, Kim TJ, Kim JW, Kim SM, Bae DS et al (2013) Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer. Obstet Gynecol 121(1):136\u2013142","journal-title":"Obstet Gynecol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-021-06320-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-021-06320-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-021-06320-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T10:13:58Z","timestamp":1650190438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-021-06320-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6320"],"URL":"https:\/\/doi.org\/10.1007\/s00404-021-06320-3","relation":{},"ISSN":["1432-0711"],"issn-type":[{"type":"electronic","value":"1432-0711"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research study was conducted retrospectively from data obtained for clinical purposes. The Peking University People\u2019s Hospital Research Ethics Committee has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}